- Not Fee assured
- Verified this account
- Paediatric gastroenterology, hepatology & nutrition
Dr Fell is lead paediatric gastroenterologist at Chelsea and Westminster Hospital, and Honorary Reader at Imperial College. He runs the regional paediatric IBD for NW London, with a transition clinic to adult service within Chelsea and Westminster. He is a previous CICRA research fellow having undertaken research in mucosal inflammation and its modultaion by nutritional therapy in paediatric Crohn's disease.
He has published widely in the field of paediatric gatstoenterology, and co-authored the British Society of Paediatric Gastroenterology Hepatology and Nutrition guideline for the management of paediatric IBD. Other areas of special interest include infantile GI disorders and the intestinal consequences of food allergy.
Areas of interest
All areas of paediatric gastroenterology and nutrition (excluding hepatology).
- Colette McDonach
- Chelsea & Westminster Hospital 369 Fulham Road London SW10 9NH
- 020 3315 8628
- Verna Pentrice
- Chelsea and Westminster Hospital 369 Fulham Road London SW10 9NH
- 020 3315 3597
Anaesthetists worked with (Bupa members, please ask your consultant whether your anaesthetist is fee-assured)
Current NHS consultant posts held
Chelsea and Westminster Hosp London
Nutritional aspects of management of inflammatory bowel disease. Gastrointestinal consequences of food allergy.
Fell JM. Update of the management of inflammatory bowel disease. Arch Dis Child. 2012; 97: 78-83
Fell JM. Management of Adolescents with Inflammatory Bowel Disease
In: Inflammatory Bowel Disease - an evidence-based guide. Edited: Hart AL, Ng S tfm publishing Ltd ISBN: 978 1 903378 82 3; 2012
Fell JME. Recognition, assessment and management of eosinophilic oesophagitis. Arch Dis Child 2013; 98(9): 702-6
Fell JM, Rafeeq M, Spray C, Crooke K, Russell RK. Management of Ulcerative Colitis. Arch Dis Child 2016; 101: 469-474
Thangarajah D, Hyde M, Konteti V, Santhakumaran S, Frost G, Fell J. Systematic review: body composition in children with inflammatory bowel disease. Aliment Pharmacol Ther. 2015; 42: 142-157
Vora R, Bernardo D, Durant L, Reddi D, Hart A, Fell J, Al-Hassi H, Knight S. Age-related alterations in blood and colonic dendritic cell properties. Oncotarget Journal, 2016; in press
Aloi M, Birimberg-Schwartz L, Buderus S, Hojsak I, Fell JM, Bronsky J, Veereman G, Koletzko S, Shaoul R, Miele E, Turner D, Russell RK.
Treatment options and outcomes of pediatric inflammatory bowel disease unclassified (IBDU) compared to other IBD subtypes: a retrospective multicentre study from the IBD Porto group of ESPGHAN. Inflamm Bowel Dis 2016; 22: 1376-1383
Rampton D, Goodhand J, Joshi N, Karim A-B, Koodun Y, Barakat F, Macken L, Ward D, Iqbal T, Epstein J, Fell J, Sanderson I. Response of iron deficiency anaemia to oral iron in adolescents and adults with inflammatory bowel disease: relation to disease activity, quality of life and serum hepcidin. J Crohn’s Colitis 2016 in press
Minshall E, Patel P, Francis N, Hansel T, Warner JO, Boyle RJ, Fell J, Epstein J. Local chemokine profiling in eosinophilic esophagitis: the Synthetic Absorptive 1 Matrix test. Ped All Immunol 2016 in press
Hyams JS, Dubinsky MC, Baldassano RN, Colletti RB, Cucchiara S, Escher J, Faubion W, Fell J, Gold BD, Griffiths A, Koletzko S, Kugathasan S, Markowitz J, Ruemmele FM, Veereman G, Winter H, Masel N, Shin CR, Tang KL, Thayu M. Infliximab is not Associated with an Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric IBD. Gastroenterology 2017 in press
- MA Cambridge 1981
- MBBS London 1984
- MRCP UK 1987
- MD London 2001
Reference number 2914866
Affiliations / memberships
FRCP FRCPCH ESPGHAN BSPGHAN BSG
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.